Myelodysplastic Syndromes

Myelodysplastic syndromes (MDS) are a group of blood disorders that can lead to low blood cell counts and an increased risk of developing acute leukemia. These disorders are more common in older adults and are caused by genetic abnormalities in the bone marrow. MDS can have a variable clinical course, making it challenging to predict outcomes and classify the disease. Understanding the causes and progression of MDS is important for developing effective treatments and improving patient outcomes.